Kelsey Goodwin
Sr. Research Analyst
Research
Sector Expertise
Additional Expertise
Biotechnology
Kelsey Goodwin is a director and senior research analyst at 做厙勛圖 covering the biotechnology sector. Prior to joining 做厙勛圖 in June 2025, Goodwin spent nearly seven years at Guggenheim Securities where she was a research analyst covering the oncology sector. Prior to making the transition to Wall Street, Goodwin was a healthcare consultant for IMS Health (now IQVIA) where she worked with many of the world's leading pharmaceutical companies. Goodwin received a bachelor's degree in biology from Bowdoin College.
Universe Coverage
| Biotechnology | |
|---|---|
| BCAX | Bicara Therapeutics, Inc. |
| CGON | CG Oncology, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| JANX | Janux Therapeutics, Inc. |
| NUVL | Nuvalent, Inc. |
| RVMD | Revolution Medicines, Inc. |
| SMMT | Summit Therapeutics, Inc. |
| TNGX | Tango Therapeutics, Inc. |
| URGN | UroGen Pharma Ltd. |